Towards Regulatory-Confirmed Adaptive Clinical Trials: Machine Learning Opportunities and Solutions

• URL: http://arxiv.org/abs/2503.09226v1
• Date: Wed, 12 Mar 2025 10:17:54 GMT
• Title: Towards Regulatory-Confirmed Adaptive Clinical Trials: Machine Learning Opportunities and Solutions
• Authors: Omer Noy Klein, Alihan Hüyük, Ron Shamir, Uri Shalit, Mihaela van der Schaar,
• Abstract summary: We introduce two new objectives for future clinical trials that integrate regulatory constraints and treatment policy value for both the entire population and under-served populations.<n>We formulate Randomize First Augment Next (RFAN), a new framework for designing Phase III clinical trials.<n>Our framework consists of a standard randomized component followed by an adaptive one, jointly meant to efficiently and safely acquire and assign patients into treatment arms during the trial.
• Score: 59.28853595868749
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Randomized Controlled Trials (RCTs) are the gold standard for evaluating the effect of new medical treatments. Treatments must pass stringent regulatory conditions in order to be approved for widespread use, yet even after the regulatory barriers are crossed, real-world challenges might arise: Who should get the treatment? What is its true clinical utility? Are there discrepancies in the treatment effectiveness across diverse and under-served populations? We introduce two new objectives for future clinical trials that integrate regulatory constraints and treatment policy value for both the entire population and under-served populations, thus answering some of the questions above in advance. Designed to meet these objectives, we formulate Randomize First Augment Next (RFAN), a new framework for designing Phase III clinical trials. Our framework consists of a standard randomized component followed by an adaptive one, jointly meant to efficiently and safely acquire and assign patients into treatment arms during the trial. Then, we propose strategies for implementing RFAN based on causal, deep Bayesian active learning. Finally, we empirically evaluate the performance of our framework using synthetic and real-world semi-synthetic datasets.

Related papers

• Zero-Shot Clinical Trial Patient Matching with LLMs [40.31971412825736]
  Large language models (LLMs) offer a promising solution to automated screening. We design an LLM-based system which, given a patient's medical history as unstructured clinical text, evaluates whether that patient meets a set of inclusion criteria. Our system achieves state-of-the-art scores on the n2c2 2018 cohort selection benchmark.
  arXiv  Detail & Related papers  (2024-02-05T00:06:08Z)
• Counterfactual Prediction Under Selective Confounding [3.6860485638625673]
  This research addresses the challenge of conducting causal inference between a binary treatment and its resulting outcome when not all confounders are known. We relax the requirement of knowing all confounders under desired treatment, which we refer to as Selective Confounding. We provide both theoretical error bounds and empirical evidence of the effectiveness of our proposed scheme using synthetic and real-world child placement data.
  arXiv  Detail & Related papers  (2023-10-21T16:54:59Z)
• AutoTrial: Prompting Language Models for Clinical Trial Design [53.630479619856516]
  We present a method named AutoTrial to aid the design of clinical eligibility criteria using language models. Experiments on over 70K clinical trials verify that AutoTrial generates high-quality criteria texts.
  arXiv  Detail & Related papers  (2023-05-19T01:04:16Z)
• SPOT: Sequential Predictive Modeling of Clinical Trial Outcome with Meta-Learning [67.8195828626489]
  Clinical trials are essential to drug development but time-consuming, costly, and prone to failure. We propose Sequential Predictive mOdeling of clinical Trial outcome (SPOT) that first identifies trial topics to cluster the multi-sourced trial data into relevant trial topics. With the consideration of each trial sequence as a task, it uses a meta-learning strategy to achieve a point where the model can rapidly adapt to new tasks with minimal updates.
  arXiv  Detail & Related papers  (2023-04-07T23:04:27Z)
• Towards Fair Patient-Trial Matching via Patient-Criterion Level Fairness Constraint [50.35075018041199]
  This work proposes a fair patient-trial matching framework by generating a patient-criterion level fairness constraint. The experimental results on real-world patient-trial and patient-criterion matching tasks demonstrate that the proposed framework can successfully alleviate the predictions that tend to be biased.
  arXiv  Detail & Related papers  (2023-03-24T03:59:19Z)
• Causal Inference under Data Restrictions [0.0]
  This dissertation focuses on modern causal inference under uncertainty and data restrictions. It includes applications to neoadjuvant clinical trials, distributed data networks, and robust individualized decision making.
  arXiv  Detail & Related papers  (2023-01-20T20:14:32Z)
• Adaptive Identification of Populations with Treatment Benefit in Clinical Trials: Machine Learning Challenges and Solutions [78.31410227443102]
  We study the problem of adaptively identifying patient subpopulations that benefit from a given treatment during a confirmatory clinical trial. We propose AdaGGI and AdaGCPI, two meta-algorithms for subpopulation construction.
  arXiv  Detail & Related papers  (2022-08-11T14:27:49Z)
• Learning Individualized Treatment Rules with Estimated Translated Inverse Propensity Score [29.606141542532356]
  In this paper, we focus on learning individualized treatment rules (ITRs) to derive a treatment policy. In our framework, we cast ITRs learning as a contextual bandit problem and minimize the expected risk of the treatment policy. As a long-term goal, our derived policy might eventually lead to better clinical guidelines for the administration of IV and VP.
  arXiv  Detail & Related papers  (2020-07-02T13:13:56Z)
• DTR Bandit: Learning to Make Response-Adaptive Decisions With Low Regret [59.81290762273153]
  Dynamic treatment regimes (DTRs) are personalized, adaptive, multi-stage treatment plans that adapt treatment decisions to an individual's initial features and to intermediate outcomes and features at each subsequent stage. We propose a novel algorithm that, by carefully balancing exploration and exploitation, is guaranteed to achieve rate-optimal regret when the transition and reward models are linear.
  arXiv  Detail & Related papers  (2020-05-06T13:03:42Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.